Indecainide

CHEMBL1201242 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
308.4 g/mol
LogP
3.0
Phase
4

This antiarrhythmic medication works by blocking sodium channels in heart cells to slow abnormal electrical signals that cause certain irregular heart rhythms. Like other Class IC antiarrhythmics, it carries risks that limit its use to specific arrhythmia types.

Masse moléculaire

308,4000 g/mol

LogP

3,00

TPSA

55,10 Ų

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21

InChI

InChI=1S/C20H24N2O/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23)

Molecular Formula

C20H24N2O

HBD / HBA

2 / 2

Liaisons Rotatives

6

Atomes Lourds

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This antiarrhythmic medication works by blocking sodium channels in heart cells to slow abnormal electrical signals that cause certain irregular heart rhythms. Like other Class IC antiarrhythmics, it carries risks that limit its use to specific arrhythmia types.

Yes, Indecainide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201242. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 52195. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.